Biologic activity of LY5 in sarcoma cell lines. by Peter Y. Yu (4281448)

VANGL2 recruits NLRP3 to OPTN for selective autophagic degradation. by Huaji Jiang (16907514)

VANGL2 recruits MARCH8 to promote the K27-linked ubiquitination of NLRP3. by Huaji Jiang (16907514)

Glucose-lowering efficacy. by Sungmin Kim (628527)

Subjects:

eGFR values and mean eGFR change after the use of dulaglutide. by Sungmin Kim (628527)

Subjects:

Baseline characteristics. by Sungmin Kim (628527)

Subjects:

The incidence rate of progression from microalbuminuria to proteinuria with dulaglutide use. by Sungmin Kim (628527)

Subjects:

Clinical factors affecting renal response to dulaglutide. by Sungmin Kim (628527)

Subjects:

The IC50 value of Tan in normal esophageal HET-1A cells. by Dong Yang (141041)

Assessment of exoprotein concentration in a 50-mL culture of MH96. by Marion Schoof (11999106)

The T37A substitution increases both H5N6 M1 protein stability and H5N6 viral replication in mammals. by Chenxi Wang (284364)

(a) Tuberculosis (TB) incidence rate of 90 countries in 1990 and (b) TB mortality rate of 28 countries in 1950, according to the BCG vaccination status in 2015. by Kazuo Inoue (302545)

The effect of α-MSH treatment on the permeability of cytokine treated Caco-2 monolayers. by Judit Váradi (507449)

The effect of α-MSH treatment on the immunostaining of tight juntion proteins claudin-4 and ZO-1 in cytokine treated Caco-2 cells. by Judit Váradi (507449)

Subject demographic data in five-year buckets. by David Romero-Bascones (14265633)

A representative PCV case of 83 years old man with a 95-month treatment period and 27-month persistent fluid. by Chang-Chi Weng (8362725)

The effect of different concentrations of α-MSH on the electrical resistance of cytokine treated Caco-2 monolayers. by Judit Váradi (507449)

Preliminary dose-response experiments. by Noelia Torremadé (3687523)

Flowchart of patients. by Seydou Goro (17847203)

Subjects:

Inactivation of one allele of FT5. by Sophia Bigot (16469992)